NFKB1 and atherosclerosis: Our finding that HIPER has a potent ability to decrease NF-κB and MAP kinase activation, and therefore inflammatory gene expression, suggests that HIPER could be beneficial against a number of inflammatory conditions where cell adhesion molecules and monocyte adhesion are an underlying pathogenic mechanism that includes atherosclerosis.